The annual Swedish Update in Inflammatory Bowel Disease course will review new and forthcoming medical and surgical therapeutic approaches in IBD and its associated manifestations, as well their impact on the current management of these conditions
By the end of this activity, participants will be able to assess the latest evidence on IBD management, including clinical trial comparisons, mucosal healing, neoplasia surveillance, and combination therapies. They will also gain knowledge on emerging treatments, the role of the multidisciplinary care team, and the safety and efficacy of biosimilars in IBD.